Dual specificity phosphatase 6 as a new therapeutic target candidate for epithelial ovarian cancer

Epithelial ovarian cancer (EOC) is a fatal disease for which methods of early detection are not yet available (1). The current standard treatment for EOC is tumor debulking surgery and systemic chemotherapy consisting of taxane and platinum-based agents (2).